Sclerosing stromal tumors of the ovary: A clinicopathologic, immunohistochemical and cytogenetic analysis of three cases

European Journal of Gynaecological Oncology

Volumn 25, Issue 2, 2004, Pages 257-260

  Kostopoulou, E ^a,b   Moulla, A ^a   Giakoustidis, D ^a   Leontsini, M ^a  

^a Aristotle University and Hippokration General Hospital   (Greece)

^b NONE   (Greece)

Author keywords

Chromosome 12; Estrogen receptor ; Estrogen receptor ; Progesterone receptor; Sclerosing stromal tumor

Indexed keywords

BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; CALRETININ; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MELAN A; PROGESTERONE RECEPTOR; PROTEIN ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CELL ULTRASTRUCTURE; CHROMOSOME ABERRATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENTAL FINDING; OVARY CANCER; OVARY SCLEROSING STROMAL TUMOR; PROTEIN EXPRESSION; TISSUE SECTION; TRISOMY 12; TRISOMY 7;

ADOLESCENT; ADULT; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; OVARIAN NEOPLASMS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEX CORD-GONADAL STROMAL TUMORS; TRISOMY;

EID: 1442303059     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chalvardjian A., Scully R.E.: "Sclerosing stromal tumors of the ovary". Cancer, 1973, 31, 664.
2. Ferrier A.: "Introduction, clinical perspective, and principles of management". In: Russell P., Farnsworth A. (eds.) "Surgical Pathology of the Ovaries". New York, Churchill Livingstone, 1997, 395.
3. Saitoh A., Tsutsumi Y., Osamura Y., Watanabe K.: "Sclerosing stromal tumor of the ovary". Arch. Pathol. Lab. Med., 1989, 113, 372.
4. Shaw J.A., Dabbs D., Geisinger K.: "Sclerosing stromal tumor of the ovary: An ultrastructural and immunohistochemical analysis with histogenetic considerations". Ultrastruct. Pathol., 1992, 16, 363.
5. Kawauchi S., Tsuji T., Kaku T., Kamura T., Nakano H., Tsuneyoshi M.: "Sclerosing stromal tumor of the ovary: A clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature". Am. J. Surg. Pathol., 1998, 22, 83.
6. Lifschitz-Mercer B., Open M., Kushnir I., Jacob N., Caspi B., Czernobilsky B.: "Hyaline globules and progesterone receptors in an ovarian sclerosing stromal tumor". Histopathol., 1995, 27, 195.
7. Stylianidou A., Varras M., Akrivis C., Fylaktidou A., Stefanaki S., Antoniou N.: "Sclerosing stromal tumor of the ovary: A case report and review of the literature". Eur. J. Gynecol. Oncol., 2001, 22, 300.
8. Marelli G., Carinelli S., Mariani A., Frigerio L., Ferrari A.: "Sclerosing stromal tumor of the ovary. Report of eight cases and review of the literature". Eur. J. Obstet. Gynecol. Reprod. Biol., 1998, 76, 85.
9. Fujimura M., Hidaka T., Kataoka K., Yamakawa Y., Akada S., Teranishi A., Saito S.: "Absence of estrogen receptor-α expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma". Am. J. Surg. Pathol., 2001, 25, 667.
10. Lau K., Mok S., Ho S. Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells". Proc. Natl. Acad. Sci., 1999, 96, 5722.
11. Fujimoto J., Sakaguchi H., Aoki I., Toyoki H., Tamaya T.: "Clinical implications of the expression of estrogen receptor-α and -β in primary and metastatic lesions of uterine endometrial cancers". Oncology, 2002, 62, 269.
12. Chu S., Mamers P., Burger H.G., Fuller P.J.: "Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors". J. Clin. Endocrinol. Metab., 2000, 85, 1200.
13. Shashi I., Golden W., von Kap-Herr C., Andersen W., Gaffey M.: "Interphase FISH for trisomy 12 on archival ovarian sex cordstromal tumors". Gynecol. Oncol., 1994, 55, 349.
14. Tsuji T., Kawauchi S., Utsunomija T., Nagata Y., Tsuneyoshi M.: "Fibrosarcoma versus cellular fibroma of the ovary". Am. J. Surg. Pathol., 1997, 21, 52.
15. Halperin D., Visscher D.W., Wallis T., Lawrence W.D.: "Evaluation of chromosome 12 copy number in ovarian granulosa cell tumors using interphase cytogenetics" Int. J. Gynecol. Pathol., 1995, 14, 319.
16. Persons D.L., Hartmann L.C., Herath J.F., Keeney G.L., Jenkinns R.B.: "Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors". Am. J. Clin. Pathol., 1994, 102, 775.
17. Manegold E., Tietze L., Gunther K., Fleischer A., Amo-Takyi B., Schroder W., Handt S.: "Trisomy 8 as a sole karyotypic aberration in an ovarian metastasizing Sertoli-Leydig cell tumor". Hum. Pathol., 2001, 32, 559.
18. McCluggage W.G., Maxwell P.: "Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours". Histopathology, 2001, 38, 403.
19. McCluggage W.G.: "Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms". J. Clin. Pathol., 2000, 53, 327.
20. Busam K.J., Iversen K., Coplan K., Old L., Stockert E., Chen Y., McGregor D., Jungbluth A.: "Immunoreactivity for A103, an antibody to Melan-A (Mart-1), in adrenocortical and other steroid tumors". Am. J. Surg. Pathol., 1998, 22, 57.
21. Stewart C., Nandini C., Richmond J.: "Value of A 103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours". J. Clin. Pathol., 2000, 53, 206.
22. Fuller P., Chu S., Fikret S., Burger H.: "Molecular pathogenesis of granulosa cell tumors". Mol. Cell. Endocrinol., 2002, 191, 89.
23. Loy T., Phillips R., Linder C.: "A 103 immunostaining in the diagnosis of adrenal cortical tumors". Arch. Pathol. Lab. Med., 2002, 126, 170.
24. Damjanov I., Drobnjak P., Gritzelj V., Longhino N.: "Sclerosing stromal tumor of the ovary: a hormonal and ultrastructural analysis". Obstet. Gynecol., 1975, 45, 675.
25. Quinn M., Oster A., Fortune D., Hudson B.: "Sclerosing stromal tumor of the ovary: case report with endocrine studies". Br. J. Obstet. Gynaecol., 1981, 88, 555.
26. Tiltman A., Haffajee Z.: "Sclerosing stromal tumors, thecomas nad fibromas of the ovary: An immunohistochemical profile". Int. J. Gynecol. Pathol., 1999, 18, 254.
27. Doglioni C., DeiTos A., Laurino L. et al.: "Calretinin: A novel immunohi-stochemical marker for mesothelioma". Am. J. Surg. Pathol., 1996, 20, 1037.
28. Cao Q.J., Jones J., Li M.: "Expression of calretinin in human ovary, testis and ovarian sex cord-stromal tumors". Int. J. Gynecol. Pathol., 2001, 20, 346.
29. Movahedi-Lankarani S., Kurman R.J.: "Calretinin, a more sensitive but less specific marker than α-inhibin for ovarian sex cordstromal neoplasms". Am. J. Surg. Pathol., 2002, 26, 1477.
30. Ordonez N.: "Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma". Mod. Pathol., 1998, 11, 929.
31. Wieczorek T., Krane J.: "Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations". Cancer (Cancer Cytopathol.), 2000, 90, 312.
32. Lopes J., Seruca R., Hall A., Branco P., Castedo S.: "Cytogenetic study of a sclerosing stromal tumor of the ovary". Cancer Genet. Cytogenet., 1990, 49, 103.
33. Taruscio D., Carcangiu M.L., Ward D.C.: "Detection of trisomy 12 on ovarian sex cord stromal tumors by fluorescence in situ hybridization". Diagn. Molec. Pathol., 1993, 2, 94.